AdvaMeds Latest Appointee Discusses New Role

AdvaMed’s Latest Appointee Discusses New Role

J.C. Scott has joined the Advanced Medical Technology Association (AdvaMed) as senior executive vice president and director of government affairs. He succeeds Brett Loper, who now is policy director for Ohio Republican House Speaker John Boehner.

In his new position, Scott will lobby state and federal lawmakers as well as medical device regulators on behalf of member companies. His first official day of work was April 11.

“I was very excited for the opportunity to join AdvaMed,” Scott said in an interview with Medical Product Outsourcing. “It is a well-established and respected organization, and being given the opportunity to lead its advocacy efforts marks a real personal milestone in my career.”

Scott previously was senior vice president of federal relations for the American Council of Life Insurers (ACLI), where he worked for seven years. He led lobbying efforts on the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as on various tax and retirement security initiatives. Before joining ACLI, Scott served as deputy director for policy at the House Republican Conference and in various capacities for former U.S. Rep. Deborah Pryce (R-Ohio).

“We are thrilled to welcome J.C.,” AdvaMed President and CEO Stephen J. Ubl said in a written statement. “He has a wealth of experience putting together winning strategies. He understands the importance of approaching complex policy issues with data-driven arguments and shares our commitment to keeping patient needs at the center of our advocacy.”

Scott, who believes in a team-oriented approach to lobbying important issues,noted the similarities between his former and current industries.

[“The ACLI], like AdvaMed, has a large and diverse membership, so helping drive consensus to get the best solution will be an important part of my job,” Scott told MPO. “There is no shortage of challenges for the device industry—with the pending reauthorization of the [Medical Device User Fee and Modernization Act] and our efforts to bring predictability and efficiency back to the [U.S. Food and Drug Administration] review process, there is a lot of work to be done.”

To get up to speed on device-related issues, Scott hopes to meet with various member companies in the next few months.

“I believe that seeing what companies do firsthand will be an important part of my education,” said Scott, who holds a bachelor’s degree from Duke University in Durham, N.C., and a law degree from Georgetown University in Washington, D.C.

There may be a lot of work to be done and a plethora of details to learn, but Scott insisted he is up to the challenge.

“The medical device industry provides life-changing innovative technology that improves people’s lives,” he said. “It’s also an industry that is built on small businesses and entrepreneurship, creates well-paying jobs, and has continued to grow even during tough economic times; there is a great story for the industry to tell on Capitol Hill and beyond.”

Xeridiem AnnouncesNew Vice President of Business Development

Renae Moomjian has joined Xeridiem Medical Devices Inc. as its vice president of business development, overseeing growth of the 25-year-old company’s design and development services.

“Renae brings over 15 years of sales, marketing and business development leadership, driving top and bottom line revenue growth in medical device companies,” President Joseph Lee said. “She has earned a reputation as a trusted advisor with many medical device companies here in the U.S. as well as others in global markets from Europe to Asia.”

Before being hired at Xeridiem, Moomjian was the general manager of the blood collection and processing division of SEBRA (also known as Engineering and Research Associates Inc.), which was acquired in September 2009 by Haemonetics Corporation. Moomjian also held the positions of sales and marketing director, new business development director, and electrophysiology program manager at SEBRA. Prior to her tenure at SEBRA, Moomjian was cardiovascular sales specialist for global biopharmaceutical giant AstraZeneca.

Xeridiem is based in Tucson, Ariz. It is part of Fenner PLC, which is headquartered in East Yorkshire, United Kingdom.

New President Namedat Cadence

Alan Connor has joined Staunton, Va.-based Cadence Inc. as president. Connor joins the company following years in key leadership roles for major healthcare and life-science companies, including most recently as the vice president and general manager of Orthopedic Specialties for MicroAire Surgical Instruments in Charlottesville, Va.

Prior to MicroAire, Alan worked at Medrad, Inc., a medical device division of Bayer-Schering Pharma, where he gainedexperience in global supply chain management, Lean manufacturing, marketing and new product development.

“We are excited to have Alan as a key member of our executive team,” said Peter Harris, CEO.
“The addition of Alan strengthens our comitment to excellence in metals manufacturing for the healthcare and life science markets.”

According to Harris, Connor also has a proven track record of building strong organizations and customer relationships while improving operating efficiencies.

Cadence is a metals manufacturing company focused on new medical technologies, such as minimally invasive devices.

Vice President of Operations Announced By Ergoresearch

Ergoresearch Ltd. has appointed Frédéric Petit vice president of operations.

“This appointment strengthens the current management team,” Sylvain Boucher, president and CEO of the Montreal, Quebec-based company, said. “Mr. Petit’s profound knowledge of the company, the market in which it evolves and his skills in managing human resources will bring a valued contribution to the company’s future endeavors.”

Previously, Petit was director of operations for Clinique de Pied Équilibre, a division of Ergoresearch, which he joined in 2007.

“I am looking forward to the challenges this position will provide,” Petit said. “My experience and competence will contribute to the company’s growth strategy.”

Ergoresearch and its subsidiaries, Clinique du Pied Équilibre and Orthoconcept, manufacture general and foot orthotics.

ReVision Optics Names New CEO and President

ReVision Optics, Inc. (RVO) has appointed John T. Kilcoyne CEO and president. Kilcoyne will succeed J. Randy Alexander, who will become board chairman.

Kilcoyne brings nearly 30 years of experience to the position; he served as chairman and CEO of Micrus Endovascular Corporation until it was acquired by Johnson & Johnson in September 2010. From 2002 to 2004, he was president and CEO of Solace Therapeutics, a Framingham, Mass.-based emerging medical device company that develops and commercializes office-based treatments for bladder disorders. He also served as president and CEO of Endonetics Inc. from 1997 to 2001. The privately held San Diego firm, which developed technologies for the diagnosis and treatment of gastroesophageal reflux disease, was purchased by Medtronic Inc. in December 2001.

“I am honored to join RVO at this time in their development,” Kilcoyne said. “The potential for their technology and the depth of experience of their employees made this the right choice.”

Alexander said Kilcoyne’s background made him a prime candidate for the job.

“John’s broad range of experience in the medical device industry and his demonstrated ability to understand the needs of patients and physicians made him the best person for this position,” Alexander said. “As RVO moves from our research and development stage into commercialization, it’s more important than ever to have someone with John’s background at the helm. We are delighted that he has joined our company.”

ReVision Optics is a privately held company that focuses on custom optical solutions for vision correction. The company is based in Lake Forest, Calif.

Orthofix Names New CFO

Orthofix International N.V. has promoted Brian McCollum to chief financial officer. McCollum, who had been serving as interim CFO since Jan. 1, officially assumed his new role on March 1.

“We are delighted to promote Brian into the CFO position,” Alan Milinazzo, Orthofix president and CEO, said in a formal statement. “Throughout his 10-year tenure with Orthofix he has taken on roles of increasing responsibility, including successfully serving as the vice president of finance for our largest domestic and international business units which gives him tremendous insight into our business worldwide.”

Last year, executives named McCollum senior vice president of finance. He joined Orthofix’s corporate finance group in 2001, eventually advancing to the position of corporate controller. In 2006, McCollum was named vice president of finance, Americas, and two years later became vice president of international finance and group treasurer. Prior to joining Orthofix, McCollum was a senior audit associate with PricewaterhouseCoopers LLP.

He received his Bachelors degree in business administration with a concentration in accounting from St. Andrews Presbyterian College in Laurinburg, N.C.

Orthofix is a global medical device company headquartered in Curaco, Netherlands Antilles.

New VPs Named at AccuRounds

AccuRounds has promoted Patrick O’Connell to vice president of operations and Joseph Barry to vice president of sales.

O’Connell has been the operations manager at AccuRounds for eight years and is credited with the implementation of Lean strategies that resulted in better efficiency and higher productivity at the firm. He will oversee operational excellence throughout the company.

“[O’Connell] has been instrumental in establishing a Lean mindset throughout the company, resulting in daily process improvement activity,” said Michael Tamasi, president and CEO.

Barry joined AccuRounds as a sales manager in 2004, and is credited with a sales growth of 85 percent since that time, according to company executives. Before joining AccuRounds, he held various sales and management positions in the metals industry.

“[Barry] has had a positive impact, creating solid relationships with customers and managing their requirements effectively,” Tamasi said.

Founded in 1976, Avon, Mass.-based AccuRounds manufactures precision custom cylindrical components.